
Aduhelm approval amplifies amyloid assays
Biogen needs blood tests for amyloid beta to progress quickly – and several are in the pipeline.

Diasorin heads to the US with $1.8bn Luminex deal
And consolidation in the diagnostics space is only just beginning.

Adaptive’s Covid-19 T-cell test hits the US
As with antibodies, the next step will be proving that T-cells can grant immunity.

US cuts fees for Covid-19 tests
Slower labs are to be paid less for Covid-19 tests, but will the move actually speed things up?